Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 399 of 6351
-
Brain tumor trial aims to find kinder chemo for toddlers
Disease control Not yet recruitingThis is a trial to compare neurocognitive outcomes in the intent-to-treat population 2.5 years after diagnosis between patients with newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC amplified MF randomized to the interventional arms A ("Head Start 4") or B (HIT-SK…
Phase 3 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New radioactive therapy targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingIn this study it is aimed to analyze the efficacy and safety of Tb-161 PSMA I\&T in the 7.4 GBq activity in a large patient group of Lu-177 PSMA naïve mCRPC patients. 3 cycles of Tb-161 PSMA will be administered with 6 weeks periods. After each cycle a triple bed quantitative sin…
Phase 2 • Sponsor: Ankara University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New oral drug could replace steroids for severe colitis Flare-Ups
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the oral medication upadacitinib can safely and effectively treat acute severe ulcerative colitis (ASUC) in adults who are hospitalized. It will also evaluate whether upadacitinib can be used without corticosteroids during initial tr…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New Pre-Surgery combo aims to boost cancer fight in stomach and esophageal tumors
Disease control Not yet recruitingThis trial is designed to evaluate a total neoadjuvant approach using D-FLOT as the new standard backbone in patients with resectable esophagogastric adenocarcinoma. It addresses major limitations of current treatment paradigms, builds directly on the strong clinical signal from …
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could viruses be the new antibiotics for joint infections?
Disease control Not yet recruitingTotal joint replacements are effective for chronic pain but can lead to Prosthetic Joint Infections (PJI), primarily caused by Staphylococcus aureus and resistant to antibiotics. Standard treatment involves DAIR surgery and antibiotics, but there's a need for better solutions due…
Phase 2 • Sponsor: Phagenix • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a diabetes pill save lives in septic shock?
Disease control Not yet recruitingMicrocirculatory dysfunction is a key driver of organ failure and mortality in septic shock, characterized by endothelial injury and impaired vasoregulation. Despite its strong prognostic value, it remains unaddressed by current therapies. SGLT-2 inhibitors (SGLT-2i) have shown p…
Phase 3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
Disease control Not yet recruitingThe GISCO study plans to determine whether 8-week therapy is just as effective as 26-week cortisone therapy for treating giant cell arteritis * with tocilizumab, * while using less cortisone.
Phase 3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New trial aims to shield hearts from chemo side effects
Prevention Not yet recruitingThis project aims to determine the benefits of the dual SGLT1/2 inhibition as prophylactic treatment to prevent anthracycline-related cardiotoxicity.
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New proton therapy trial aims to reduce side effects in nasopharyngeal cancer
Disease control Not yet recruitingProton therapy for nasopharyngeal carcinoma can reduce radiotherapy-related toxic reactions, and some retrospective studies have found that proton therapy improves the survival of patients with nasopharyngeal carcinoma. However, high-level prospective clinical evidence is still l…
Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
CAR-T therapy takes on lupus and scleroderma in early trial
Disease control Recruiting nowAID is a phase I multi-cohort study to assess the safety and tolerability of zamtocabtagene autoleucel (zamto-cel) in patients with refractory autoimmune diseases (SLE-Non renal, SLE-LN, SSc/dcSSc) after receiving standard therapy.
Phase 1 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for high altitude emergencies: study tests Life-Saving treatments
Disease control Not yet recruitingThis study aims to establish a key technical system for the diagnosis and treatment of severe acute mountain sickness based on real-world clinical data in Xizang, develop standardized diagnosis and treatment protocols and an intelligent early warning model, validate its efficacy …
Sponsor: Tibet Autonomous Region People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could less radiation be enough for some lymphoma patients?
Disease control Recruiting nowThis study is designed to evaluate the efficacy and safety of reduced-intensity radiotherapy for stage I/II low-risk nasal-type NK/T-cell lymphoma that has achieved complete remission after chemotherapy.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
One pill to tackle three heart risks: could a polypill cut cardiovascular disease?
Disease control Not yet recruitingThe Polypill Approach for Multiple Cardiovascular Risk Factors (PACIF) trial is a multicenter randomized controlled trial that will test the effectiveness and safety of a fixed-dose combination strategy for integrated management of hypertension, dyslipidemia, and diabetes among a…
Sponsor: China Medical University, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Two doses of rituximab before transplant may shield children from Epstein-Barr virus
Disease control Recruiting nowThe goal of this clinical trial is to learn if adding rituximab to the ATG-based Protocol can prevent Epstein-Barr virus (EBV) from reactivating in children who have received an allogeneic haploidentical hematopoietic stem cell transplant. It will also learn about the safety of a…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a gentle surgical approach improve outcomes after deep brain bleeding?
Disease control Not yet recruitingThis observational cohort study evaluates the real-world effectiveness and safety of minimally invasive surgery (MIS) versus standard medical management in adults with spontaneous deep intracerebral hemorrhage. Patients presenting to Tam Anh General Hospital and People's Hospital…
Sponsor: Tam Anh Research Institute • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Brain markers may reveal who responds best to suicide treatments
Knowledge-focused Not yet recruitingThis is a prospective observational biomarker study assessing changes in clinical, behavioral, neuroimaging, and neurophysiological measurer following ketamine/esketamine or electroconvulsive therapy (ECT) in adults with suicidal thoughts or behaviors.
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can removing bladder tumors in one piece improve cancer outcomes?
Disease control Not yet recruitingThis is a prospective, multi-centre randomised trial comparing between cTURBT plus 1-year BCG therapy, and ERBT plus 1-year BCG therapy, in patients with intermediate-risk or high-risk NMIBC.
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
Disease control Not yet recruitingThis multicenter, three-arm randomized controlled trial will evaluate the effects of early time-restricted eating and staple food reduction, each combined with an app-supported exercise intervention, on body weight and glycemic control among adults with obesity and abnormal gluco…
Sponsor: Peking University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a diabetes drug help fight liver cancer? a trial puts it to the test
Disease control Not yet recruitingThe goal of this interventional study (clinical trial) is to evaluate the efficacy and safety of adding dapagliflozin to first-line standard therapy in patients with unresectable hepatocellular carcinoma (HCC) and comorbid metabolic syndrome. The main questions it aims to answer…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
The hearing test that could see what standard exams miss
Diagnosis Not yet recruitingThis study aims to investigate the underlying mechanisms of speech-in-noise difficulties in patients with normal conventional pure-tone and speech audiometry. Participants presenting with complaints of impaired speech understanding in noisy environments will undergo a comprehensi…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC